Tri Locum Partners LP Buys Horizon Therapeutics PLC, Regeneron Pharmaceuticals Inc, Bristol-Myers Squibb Company, Sells AbbVie Inc, Viatris Inc, Laboratory Corp of America Holdings

Investment company Tri Locum Partners LP (Current Portfolio) buys Horizon Therapeutics PLC, Regeneron Pharmaceuticals Inc, Bristol-Myers Squibb Company, Jazz Pharmaceuticals PLC, Humana Inc, sells AbbVie Inc, Viatris Inc, Laboratory Corp of America Holdings, ChemoCentryx Inc, Zai Lab during the 3-months ended 2021Q1, according to the most recent filings of the investment company, Tri Locum Partners LP. As of 2021Q1, Tri Locum Partners LP owns 33 stocks with a total value of $400 million. These are the details of the buys and sells.

For the details of Tri Locum Partners LP's stock buys and sells, go to https://www.gurufocus.com/guru/tri+locum+partners+lp/current-portfolio/portfolio

These are the top 5 holdings of Tri Locum Partners LP
  1. Walgreens Boots Alliance Inc (WBA) - 770,000 shares, 10.56% of the total portfolio.
  2. Walgreens Boots Alliance Inc (WBA) - 770,000 shares, 10.56% of the total portfolio.
  3. Regeneron Pharmaceuticals Inc (REGN) - 64,705 shares, 7.65% of the total portfolio. Shares added by 520.79%
  4. Medtronic PLC (MDT) - 239,644 shares, 7.07% of the total portfolio. Shares added by 17.39%
  5. Johnson & Johnson (JNJ) - 168,634 shares, 6.93% of the total portfolio. Shares added by 3.69%
New Purchase: Horizon Therapeutics PLC (HZNP)

Tri Locum Partners LP initiated holding in Horizon Therapeutics PLC. The purchase prices were between $71.83 and $95.48, with an estimated average price of $84.49. The stock is now traded at around $91.900000. The impact to a portfolio due to this purchase was 6.75%. The holding were 293,426 shares as of 2021-03-31.

New Purchase: Jazz Pharmaceuticals PLC (JAZZ)

Tri Locum Partners LP initiated holding in Jazz Pharmaceuticals PLC. The purchase prices were between $150.19 and $173.5, with an estimated average price of $164.6. The stock is now traded at around $175.210000. The impact to a portfolio due to this purchase was 4.53%. The holding were 110,382 shares as of 2021-03-31.

New Purchase: Humana Inc (HUM)

Tri Locum Partners LP initiated holding in Humana Inc. The purchase prices were between $375.15 and $447.69, with an estimated average price of $398.88. The stock is now traded at around $445.060000. The impact to a portfolio due to this purchase was 3.74%. The holding were 35,693 shares as of 2021-03-31.

New Purchase: Nuance Communications Inc (NUAN)

Tri Locum Partners LP initiated holding in Nuance Communications Inc. The purchase prices were between $40.35 and $50.51, with an estimated average price of $46.02. The stock is now traded at around $52.870000. The impact to a portfolio due to this purchase was 3.64%. The holding were 333,482 shares as of 2021-03-31.

New Purchase: Aclaris Therapeutics Inc (ACRS)

Tri Locum Partners LP initiated holding in Aclaris Therapeutics Inc. The purchase prices were between $5.86 and $27.73, with an estimated average price of $19.63. The stock is now traded at around $22.970000. The impact to a portfolio due to this purchase was 1.03%. The holding were 164,199 shares as of 2021-03-31.

New Purchase: Celldex Therapeutics Inc (CLDX)

Tri Locum Partners LP initiated holding in Celldex Therapeutics Inc. The purchase prices were between $16.19 and $29.91, with an estimated average price of $22.98. The stock is now traded at around $27.000000. The impact to a portfolio due to this purchase was 1.01%. The holding were 196,672 shares as of 2021-03-31.

Added: Regeneron Pharmaceuticals Inc (REGN)

Tri Locum Partners LP added to a holding in Regeneron Pharmaceuticals Inc by 520.79%. The purchase prices were between $446.73 and $548.2, with an estimated average price of $486.85. The stock is now traded at around $510.270000. The impact to a portfolio due to this purchase was 6.42%. The holding were 64,705 shares as of 2021-03-31.

Added: Bristol-Myers Squibb Company (BMY)

Tri Locum Partners LP added to a holding in Bristol-Myers Squibb Company by 9215.99%. The purchase prices were between $59.34 and $66.74, with an estimated average price of $62.18. The stock is now traded at around $65.550000. The impact to a portfolio due to this purchase was 6.1%. The holding were 390,992 shares as of 2021-03-31.

Added: 9 Meters Biopharma Inc (NMTR)

Tri Locum Partners LP added to a holding in 9 Meters Biopharma Inc by 377.73%. The purchase prices were between $0.84 and $2.16, with an estimated average price of $1.54. The stock is now traded at around $1.190000. The impact to a portfolio due to this purchase was 1.53%. The holding were 6,644,337 shares as of 2021-03-31.

Added: Myovant Sciences Ltd (MYOV)

Tri Locum Partners LP added to a holding in Myovant Sciences Ltd by 684.90%. The purchase prices were between $20.46 and $25.18, with an estimated average price of $22.74. The stock is now traded at around $21.830000. The impact to a portfolio due to this purchase was 1.44%. The holding were 321,101 shares as of 2021-03-31.

Added: TG Therapeutics Inc (TGTX)

Tri Locum Partners LP added to a holding in TG Therapeutics Inc by 112.52%. The purchase prices were between $41.61 and $54.3, with an estimated average price of $48.04. The stock is now traded at around $32.525000. The impact to a portfolio due to this purchase was 0.95%. The holding were 148,620 shares as of 2021-03-31.

Added: Black Diamond Therapeutics Inc (BDTX)

Tri Locum Partners LP added to a holding in Black Diamond Therapeutics Inc by 1289.78%. The purchase prices were between $22.23 and $34.75, with an estimated average price of $26.97. The stock is now traded at around $22.230000. The impact to a portfolio due to this purchase was 0.81%. The holding were 142,911 shares as of 2021-03-31.

Sold Out: AbbVie Inc (ABBV)

Tri Locum Partners LP sold out a holding in AbbVie Inc. The sale prices were between $102.3 and $112.62, with an estimated average price of $106.92.

Sold Out: Viatris Inc (VTRS)

Tri Locum Partners LP sold out a holding in Viatris Inc. The sale prices were between $13.59 and $18.54, with an estimated average price of $16.33.

Sold Out: Laboratory Corp of America Holdings (LH)

Tri Locum Partners LP sold out a holding in Laboratory Corp of America Holdings. The sale prices were between $204.88 and $255.03, with an estimated average price of $233.67.

Sold Out: ChemoCentryx Inc (CCXI)

Tri Locum Partners LP sold out a holding in ChemoCentryx Inc. The sale prices were between $49.53 and $68.4, with an estimated average price of $60.19.

Sold Out: Zai Lab Ltd (ZLAB)

Tri Locum Partners LP sold out a holding in Zai Lab Ltd. The sale prices were between $126.27 and $191.71, with an estimated average price of $155.27.

Sold Out: Blueprint Medicines Corp (BPMC)

Tri Locum Partners LP sold out a holding in Blueprint Medicines Corp. The sale prices were between $90.71 and $108.28, with an estimated average price of $99.79.



Here is the complete portfolio of Tri Locum Partners LP. Also check out:

1. Tri Locum Partners LP's Undervalued Stocks
2. Tri Locum Partners LP's Top Growth Companies, and
3. Tri Locum Partners LP's High Yield stocks
4. Stocks that Tri Locum Partners LP keeps buying